
Human zzso zzso zzso has well established beneficial effects in treating zzso forms of multiple zzso but current zzso treatment requires frequent (from daily to zzso zzso zzso A zzso zzso zzso zzso zzso zzso zzso zzso is being developed to decrease the frequency of administration and improve patient convenience and zzso We present zzso zzso and zzso zzso zzso zzso and safety of zzso zzso in zzso monkeys in support of a phase 1 clinical zzso Two zzso zzso studies and one zzso zzso toxicity study zzso with good laboratory practice were zzso The zzso of zzso zzso and zzso zzso were modeled with a zzso model, and the link between drug concentration and zzso response zzso zzso was described with an indirect zzso zzso zzso zzso showed greater exposure, longer zzso lower zzso and reduced volume of distribution than unmodified zzso zzso zzso with the pharmacology of type I zzso zzso zzso resulted in the zzso of zzso zzso a transient body temperature increase, and a zzso zzso count zzso As expected, zzso zzso to zzso zzso formed in almost all monkeys after 5 weeks of treatment, which resulted in significantly reduced drug exposure and zzso of zzso zzso There were no drug-related adverse effects at doses up to 100 zzso (11 zzso given zzso or zzso once weekly for 5 zzso The zzso level was determined to be 100 zzso (11 zzso the highest dose zzso 

